272
Views
47
CrossRef citations to date
0
Altmetric
Research Article

The effect of Aricept® in persons with persistent memory disorder following traumatic brain injury: a pilot study

, , &
Pages 809-815 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Samuel A Florentino, Mohammad H Bawany & Heather M Ma. (2022) Acetylcholinesterase inhibitors to enhance recovery from traumatic brain injury: a comprehensive review and case series. Brain Injury 36:4, pages 441-454.
Read now
Kelsey A. Campbell, Richard E. Kennedy, Robert C. Brunner, Sean D. Hollis, Ross A. Lumsden & Thomas A. Novack. (2018) The effect of donepezil on the cognitive ability early in the course of recovery from traumatic brain injury. Brain Injury 32:8, pages 972-979.
Read now
Larry D Morries, Paolo Cassano & Theodore A Henderson. (2015) Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy. Neuropsychiatric Disease and Treatment 11, pages 2159-2175.
Read now
Joyce W. Tam & Maureen Schmitter-Edgecombe. (2013) The Role of Processing Speed in the Brief Visuospatial Memory Test – Revised. The Clinical Neuropsychologist 27:6, pages 962-972.
Read now
Therese M. O’Neil-Pirozzi, Richard Goldstein, Gary E. Strangman & Mel B. Glenn. (2012) Test–re-test reliability of the Hopkins Verbal Learning Test-Revised in individuals with traumatic brain injury. Brain Injury 26:12, pages 1425-1430.
Read now
Cynthia Braden, Lenore Hawley, Jody Newman, Clare Morey, Don Gerber & Cynthia Harrison-Felix. (2010) Social communication skills group treatment: A feasibility study for persons with traumatic brain injury and comorbid conditions. Brain Injury 24:11, pages 1298-1310.
Read now
Jeffrey J. Gaines, Rebecca A. Gavett, Joshua J. Lynch, Rohit Bakshi & Ralph H. B. Benedict. (2008) New Error type and Recall Consistency Indices for the Brief Visuospatial Memory Test  – Revised: Performance in Healthy Adults and Multiple Sclerosis Patients. The Clinical Neuropsychologist 22:5, pages 851-863.
Read now
Norman A. Poole & Niruj Agrawal. (2008) Cholinomimetic agents and neurocognitive impairment following head injury: A systematic review. Brain Injury 22:7-8, pages 519-534.
Read now
Norman R Relkin. (2007) Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer’s disease. Expert Review of Neurotherapeutics 7:6, pages 735-748.
Read now
Jeffrey J. Bazarian, Frank P. Zemlan, Sohug Mookerjee & Torgney Stigbrand. (2006) Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Injury 20:7, pages 759-765.
Read now
Melissa Trovato, Beth Slomine, Frank Pidcock & James Christensen. (2006) The efficacy of donepezil hydrochloride on memory functioning in three adolescents with severe traumatic brain injury. Brain Injury 20:3, pages 339-343.
Read now
David B Arciniegas, C Alan Anderson, Jeannie Topkoff & Thomas W McAllister. (2005) Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatric Disease and Treatment 1:4, pages 311-327.
Read now

Articles from other publishers (35)

Diana Velikonja, Jennie Ponsford, Shannon Janzen, Amber Harnett, Eleni Patsakos, Mary Kennedy, Leanne Togher, Robert Teasell, Amanda McIntyre, Penny Welch-West, Ailene Kua & Mark Theodore Bayley. (2023) INCOG 2.0 Guidelines for Cognitive Rehabilitation Following Traumatic Brain Injury, Part V: Memory. Journal of Head Trauma Rehabilitation 38:1, pages 83-102.
Crossref
Jessica Traeger, Brian Hoffman, Jennifer Misencik, Alan Hoffer & Jason Makii. (2020) Pharmacologic Treatment of Neurobehavioral Sequelae Following Traumatic Brain Injury. Critical Care Nursing Quarterly 43:2, pages 172-190.
Crossref
Daniel J. Correa, Churl-Su Kwon, Susan Connors, Brandy Fureman, Vicky Whittemore, Nathalie Jetté, Gary W. Mathern & Solomon L. Moshé. (2019) Applying participatory action research in traumatic brain injury studies to prevent post-traumatic epilepsy. Neurobiology of Disease 123, pages 137-144.
Crossref
Ginger Polich, Mary Alexis Iaccarino & Ross Zafonte. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease 253 267 .
David L. Ripley, Sangeeta Driver, Ryan Stork & Mithra Maneyapanda. 2019. Rehabilitation After Traumatic Brain Injury. Rehabilitation After Traumatic Brain Injury 133 163 .
Angela Scicutella. 2019. Acquired Brain Injury. Acquired Brain Injury 227 301 .
Patricia B. de la TremblayeCorina O. BondiNaima LajudJeffrey P. ChengHannah L. RadabaughAnthony E. Kline. (2017) Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined. Journal of Neurotrauma 34:8, pages 1610-1622.
Crossref
M.A. Hernandez-Tejada & O. Brawman-Mintzer. 2017. New Therapeutics for Traumatic Brain Injury. New Therapeutics for Traumatic Brain Injury 273 285 .
Sicong Tu & Jian Tu. 2017. Neurological Regeneration. Neurological Regeneration 13 48 .
Denise D. Correa, Maria Kryza-Lacombe, Raymond E. Baser, Kathryn Beal & Lisa M. DeAngelis. (2016) Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study. Journal of Neuro-Oncology 127:2, pages 313-319.
Crossref
Samuel S. ShinC. Edward Dixon. (2015) Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury. Journal of Neurotrauma 32:19, pages 1429-1440.
Crossref
Diana Velikonja, Robyn Tate, Jennie Ponsford, Amanda McIntyre, Shannon Janzen & Mark Bayley. (2014) INCOG Recommendations for Management of Cognition Following Traumatic Brain Injury, Part V. Journal of Head Trauma Rehabilitation 29:4, pages 369-386.
Crossref
Ramon Diaz-ArrastiaPatrick M. KochanekPeter BergoldKimbra KenneyChristine E. MarxCol. Jamie B. GrimesLTC Yince LohLTC Gina E. AdamDevon OskvigKenneth C. CurleyCol. Wanda Salzer. (2014) Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward: Report of the Department of Defense Neurotrauma Pharmacology Workgroup. Journal of Neurotrauma 31:2, pages 135-158.
Crossref
Kaitlyn E. ShawCorina O. BondiSamuel H. LightLire A. MassiminoRose L. McAloonChristina M. MonacoAnthony E. Kline. (2013) Donepezil Is Ineffective in Promoting Motor and Cognitive Benefits after Controlled Cortical Impact Injury in Male Rats. Journal of Neurotrauma 30:7, pages 557-564.
Crossref
Rafat Mohammed Al Owesie & Catherine Saino Morton. (2012) Psychopharmacologic intervention after hemorrhagic basal ganglia damage. Journal of the Neurological Sciences 322:1-2, pages 77-78.
Crossref
Patricia Wheaton, Jane L. Mathias & Robert Vink. (2011) Impact of Pharmacological Treatments on Cognitive and Behavioral Outcome in the Postacute Stages of Adult Traumatic Brain Injury. Journal of Clinical Psychopharmacology 31:6, pages 745-757.
Crossref
Coleen M. Atkins. (2011) Decoding Hippocampal Signaling Deficits After Traumatic Brain Injury. Translational Stroke Research 2:4, pages 546-555.
Crossref
William P. MeehanIIIIII. (2011) Medical Therapies for Concussion. Clinics in Sports Medicine 30:1, pages 115-124.
Crossref
Jared W. Young, Susan B. Powell, Victoria Risbrough, Hugh M. Marston & Mark A. Geyer. (2009) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics 122:2, pages 150-202.
Crossref
Yong Wook Kim, Deog Young Kim, Ji-Cheol Shin, Chang-il Park & Jong Doo Lee. (2009) The Changes of Cortical Metabolism Associated With the Clinical Response to Donepezil Therapy in Traumatic Brain Injury. Clinical Neuropharmacology 32:2, pages 63-68.
Crossref
Shelli R. Kesler, Amy A. Lightbody & Allan L. Reiss. (2009) Cholinergic dysfunction in fragile X syndrome and potential intervention: A preliminary 1 H MRS study . American Journal of Medical Genetics Part A 149A:3, pages 403-407.
Crossref
David B. Arciniegas, Jonathan M. Silver & Thomas W. McAllister. (2008) Stimulants and Acetylcholinesterase Inhibitors for the Treatment of Cognitive Impairment After Traumatic Brain Injury. Psychopharm Review 43:12, pages 91-97.
Crossref
Kathleen M. Youse. (2008) Medications That Exacerbate or Induce Cognitive-Communication Deficits. Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders 18:4, pages 137-143.
Crossref
Javier Ballesteros, Itziar Güemes, Nora Ibarra & José I. Quemada. (2008) The Effectiveness of Donepezil for Cognitive Rehabilitation After Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 23:3, pages 171-180.
Crossref
Jr Granacher. 2007. Traumatic Brain Injury. Traumatic Brain Injury 363 442 .
Arun Lata Agarwal, Devdutta Biswas & Sanjay Agarwal. (2017) Donepezil in traumatic brain injury: Report of two cases. Indian Journal of Neurotrauma 04:02, pages 129-131.
Crossref
J. Helen Yoo, Maria G. Valdovinos & Dean C. Williams. (2007) Relevance of Donepezil in Enhancing Learning and Memory in Special Populations: A Review of the Literature. Journal of Autism and Developmental Disorders 37:10, pages 1883-1901.
Crossref
ANGELA SCICUTELLA. 2007. Acquired Brain Injury. Acquired Brain Injury 81 121 .
Shawn J. Kile. (2006) DIAGNOSIS AND TREATMENT OF POSTCONCUSSIVE NEUROBEHAVIORAL SYMPTOMS. CONTINUUM: Lifelong Learning in Neurology 12, pages 60-71.
Crossref
Wayne A. Gordon, Ross Zafonte, Keith Cicerone, Joshua Cantor, Margaret Brown, Lisa Lombard, Rachel Goldsmith & Tina Chandna. (2006) Traumatic Brain Injury Rehabilitation. American Journal of Physical Medicine & Rehabilitation 85:4, pages 343-382.
Crossref
S. F. Cappa, T. Benke, S. Clarke, B. Rossi, B. Stemmer & C. M. van Heugten. 2006. European Handbook of Neurological Management. European Handbook of Neurological Management 592 612 .
Izzettin Hatip-Al-Khatib, Katsunori Iwasaki, Yoshitaka Yoshimitsu, Takashi Arai, Nobuaki Egashira, Kenichi Mishima, Tomoaki Ikeda & Michihiro Fujiwara. (2005) Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats. British Journal of Pharmacology 145:8, pages 1035-1044.
Crossref
Robert S. Marin & Patricia A. Wilkosz. (2005) Disorders of Diminished Motivation. Journal of Head Trauma Rehabilitation 20:4, pages 377-388.
Crossref
Joseph Martin Alisky. (2005) Could Cholinesterase Inhibitors and Memantine Alleviate HIV Dementia?. JAIDS Journal of Acquired Immune Deficiency Syndromes 38:1, pages 113-114.
Crossref
Izzettin Hatip-Al-Khatib, Arai Takashi, Nobuaki Egashira, Katsunori Iwasaki & Michihiro Fujiwara. (2004) Comparison of the effect of TAK-147 (zanapezil) and E-2020 (donepezil) on extracellular acetylcholine level and blood flow in the ventral hippocampus of freely moving rats. Brain Research 1012:1-2, pages 169-176.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.